BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hübner M, Moellhoff N, Effinger D, Hinske CL, Hirschberger S, Wu T, Müller MB, Strauß G, Kreth FW, Kreth S. MicroRNA-93 acts as an "anti-inflammatory tumor suppressor" in glioblastoma. Neurooncol Adv 2020;2:vdaa047. [PMID: 32642700 DOI: 10.1093/noajnl/vdaa047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wach J, Apallas S, Schneider M, Güresir A, Schuss P, Herrlinger U, Vatter H, Güresir E. Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma. Front Oncol 2021;11:653614. [PMID: 33747971 DOI: 10.3389/fonc.2021.653614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Valtorta S, Salvatore D, Rainone P, Belloli S, Bertoli G, Moresco RM. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance. Int J Mol Sci 2020;21:E5631. [PMID: 32781585 DOI: 10.3390/ijms21165631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Urbantat RM, Vajkoczy P, Brandenburg S. Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma. Cancers (Basel) 2021;13:2983. [PMID: 34203660 DOI: 10.3390/cancers13122983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhou Y, Wang Y, Chen H, Xu Y, Luo Y, Deng Y, Zhang J, Shao A. Immuno-oncology: are TAM receptors in glioblastoma friends or foes? Cell Commun Signal 2021;19:11. [PMID: 33509214 DOI: 10.1186/s12964-020-00694-8] [Reference Citation Analysis]
5 Sati ISEE, Parhar I. MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma. Int J Mol Sci 2021;22:13550. [PMID: 34948346 DOI: 10.3390/ijms222413550] [Reference Citation Analysis]